Simplify Genomics leverages its proprietary Smart Genome™ platform to enhance precision medicine through advanced genomic reporting and exploration. This platform is designed to handle vast amounts of genomic data, providing rapid access to over 1.6 million interpreted variants and more than 400 million queryable records. The Smart Genome™ platform integrates clinical phenotypes and current genomic knowledge, allowing healthcare professionals to make informed clinical decisions quickly. It is particularly focused on delivering actionable insights from Whole Genome Sequencing, with a strong emphasis on monogenic hereditary risk, polygenic risk, pharmacogenomics, and health and wellness traits.

The company operates a CLIA-certified and CAP-accredited dry laboratory, ensuring that its clinical reports are both reliable and informative. The Smart Genome™ platform is built to facilitate scalable and reproducible clinical reporting, utilizing AI-informed methodologies to enhance the interpretability of genomic data. By aggregating a rich repository of public and proprietary omic and clinical data, Simplify Genomics aims to support discovery and research, ultimately transforming patient care through intelligent genomic insights.

United States

Simplify Genomics is a San Diego-based biotechnology company that provides clinical whole genome reporting and genome exploration at the speed of thought using its proprietary genome search engine.

Simplify Genomics

Company Details